UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000025560
Receipt No. R000029360
Scientific Title A multicenter, phase 1/2 study of Ramucirumab plus Nivolumab as second-line therapy in participants with gastric or GEJ cancer
Date of disclosure of the study information 2017/01/06
Last modified on 2019/01/11 18:06:13

No. Disposal Last modified on Item of update
1 Insert 2017/01/06 13:34:14
2 Update 2017/06/21 18:10:54 Recruitment status
3 Update 2018/01/16 18:56:24 Recruitment status
4 Update 2019/01/11 18:06:13 Last follow-up date
Date analysis concluded


Contact us.